Biomarkers for Psychiatric Disorders

  • Chris Turck

Table of contents

  1. Front Matter
    Pages i-x
  2. Gursharan Chana, Stephen J. Glatt, Ian P. Everall, Ming T. Tsuang
    Pages 1-21
  3. Albert Wong, Laura Feldcamp
    Pages 23-55
  4. Christoph W. Turck*, Claudia Ditzen, Eser Sayan-Ayata
    Pages 57-74
  5. Daniel Martins de Souza, Emmanuel Dias-Neto
    Pages 97-127
  6. Rima Kaddurah-Daouk, Jair C. Soares, Marlon P. Quinones
    Pages 129-162
  7. Miyako Furuta, Hiroshi Kunugi
    Pages 163-184
  8. Alessandra Mallei, Roberto Giambelli, Aram El Khoury, Susanne H. M. Gruber, Laura Musazzi, Valentina S. Barbiero et al.
    Pages 185-202
  9. Eva Drews, Astrid Becker, Andras Bilkei-Gorzo, Andreas Zimmer
    Pages 217-234
  10. Heike Tost, Andreas Meyer-Lindenberg
    Pages 235-271
  11. Mayumi Kimura, Axel Steiger
    Pages 273-298
  12. Marcelo Paez-Pereda, Markus Panhuysen
    Pages 299-314
  13. A. Serretti, A. Drago, Michael N Liebman
    Pages 315-353
  14. Irina Antonijevic, Roman Artymyshyn, Carlos Forray, Sylvia Rabacchi, Kelli Smith, Chad Swanson et al.
    Pages 355-403
  15. Enrico Domenici, Pierandrea Muglia, Emilio Merlo-Pich
    Pages 405-426
  16. Marcus Ising, Florian Holsboer
    Pages 427-443
  17. John Raelson*, Abdelmajid Belouchi
    Pages 445-471
  18. Back Matter
    Pages 523-535

About this book


Biological markers, as physiological indicators of disease, hold immense promise for diagnostics and clinical drug trials. While for other complex disorders like diabetes and heart disease a limited number of markers are at hand, there are currently no biomarkers available for psychiatric disorders. Here diagnostic tools are restricted to the evaluation of behavioral and clinical phenotypes, a severe limitation for any scientific study. As in any other disease area a major goal is therefore the identification of markers that can categorize subsets of patients in a consistent manner. This will allow a more precise definition of psychiatric disorders and in turn facilitate investigations of the pathophysiology and enhance the ability for patient treatment.

Biomarkers for Psychiatric Disorders provides discovery strategies from scientists in academia and pharma and biotech industries. By addressing the various potential uses of psychiatric biomarkers, this edited volume will interest psychiatrists, neuroscientists, and biomedical scientists working in molecular medicine, disease diagnostics, and drug development.

Christoph W. Turck is head of the Proteomics and Biomarkers branch at the Max Planck

Institute of Psychiatry and holds faculty appointments in the Department of Biochemistry at Ludwig Maximilians University Munich and the International Max Planck Research School for Molecular and Cellular Life Sciences.


Depression affective disorders biomarkers diagnosis genetics neurological brain disorders psychiatry

Editors and affiliations

  • Chris Turck

There are no affiliations available

Bibliographic information